Arkolith/Insider Trading/TNXP/Form 4

Olukotun Adeoye Y

DirectorTonix Pharmaceuticals Holding Corp. (TNXP) · full profile →Form 4 · filed Feb 28, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2024Other(J)1$1.91$20

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001839882-25-012471) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML